Peptivoice

Selank reconstitution calculator

tuftsin analog · anxiolytic

Selank is Semax's anxiolytic sibling - a tuftsin-based peptide developed by the same Russian institute, registered there for anxiety-related indications. The US gray market imports the molecule without the oversight; Western controlled trials are essentially nonexistent.

Regulatory status (August 2026). Not FDA-approved. Developed and registered in Russia as an anxiolytic (typically nasal); in the US it is a research chemical with no legal sales pathway for human use.
Reconstitution · Selankmath only - no dosing advice
0102030405060708090100U-100 · UNITS

Enter vial size, water volume, and the dose your provider gave you.

This tool converts the numbers you enter (dose ÷ concentration = volume). It never suggests a dose. The FDA has documented hospitalizations caused by mg / ml / unit conversion errors with vial-and-syringe products - if the readout surprises you, stop and verify with your prescriber or pharmacist.

Questions people actually search

Selank vs Semax - what's the difference?

Same Russian research lineage, different targets: Semax is studied for cognition and neuroprotection, Selank for anxiety (its parent molecule tuftsin is immune-related). Both are nasal-first in Russian practice and vial-based in the US gray market.

How is Selank usually dosed?

There is no US-established dose. Russian practice uses nasal drops/spray in the hundreds-of-mcg range per administration. The calculator converts whatever amount you and a clinician decide on - it does not recommend one.

Does Selank show up on drug tests?

Standard workplace panels don't screen for it. Anti-doping is a different matter - WADA's catch-all categories for non-approved substances can cover research peptides, and athlete-testing programs have flagged peptide use via specialized assays.

Read the full reconstitution guide →